Reducing Intraoperative ESKAPE (Enterococcus, S. Aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter Spp.) Transmission Via Use of an Evidence-Based, Hand Hygiene Program Optimized by OR PathTrac
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Surgical Procedure, Unspecified
- Sponsor
- University of Iowa
- Enrollment
- 39
- Locations
- 1
- Primary Endpoint
- ESKAPE transmission events with and without the body worn device
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia.
Detailed Description
A solid body of published and preliminary evidence leveraging systematic phenotypic and whole cell genome analysis and innovative surveillance technology has provided great insight into the epidemiology of perioperative bacterial transmission and healthcare-associated infection (HAI) development. This work has led us to three primary assertions that serve as the foundation of our scientific premise: 1) Further progress towards HAI prevention is needed, 2) Prevention of perioperative ESKAPE transmission is an important improvement target, and 3) An evidence-based, multi-faceted program can reduce perioperative ESKAPE transmission. Further work to generate intraoperative hand hygiene improvement is indicated. We hypothesize that the proposed program will generate sustained reductions in OR ESKAPE exposure and S. aureus transmission that will lead to sustained reductions in perioperative HAIs.
Investigators
Andrew Pugely
Principle Investigator
University of Iowa
Eligibility Criteria
Inclusion Criteria
- •Adult patients undergoing surgery requiring general anesthesia and peripheral IV and/or central line placement.
Exclusion Criteria
- •Pediatric patient, not requiring general anesthesia and/or IV/central line placement.
Outcomes
Primary Outcomes
ESKAPE transmission events with and without the body worn device
Time Frame: Up to 96 hours from the surgial procedure
Reduce the number of Enterococcus, Staphylococcus aureus, Pseudomonas, and other gram-negative (i.e., Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) transmission events
Secondary Outcomes
- 90-Day Healthcare-Associated Infections(90 days following surgery)
- The epidemiology of ESKAPE transmission events(Up to 90 days from surgery)